Novo CEO pressed by Senate to cut selling prices of being overweight, diabetes medication CEO Lars Fruergaard Jørgensen advised lawmakers the company would contemplate new talks with insurers with regard to the record costs of Wegovy and copyright whenever they pledge to maintain the medicines on their own formularies. Sanders https://trevorphxne.diowebhost.com/85691789/the-smart-trick-of-healthcare-news-that-nobody-is-discussing